NSE:MOREPENLAB   MOREPEN LABORATORI
Morepen Laboratories Gets US FDA's Approval for Anti-Allergy Drug in India

expected to touch trend line @ 55 (round bottom form)

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.